IRIS
LOGROSCINO, Giancarlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.665
EU - Europa 5.765
AS - Asia 4.674
AF - Africa 282
SA - Sud America 194
OC - Oceania 151
Continente sconosciuto - Info sul continente non disponibili 10
Totale 34.741
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.527
CN - Cina 1.641
SE - Svezia 1.016
SG - Singapore 919
IT - Italia 757
DE - Germania 753
RU - Federazione Russa 748
GB - Regno Unito 586
UA - Ucraina 577
FI - Finlandia 400
HK - Hong Kong 350
IN - India 305
FR - Francia 277
IR - Iran 230
KR - Corea 179
BR - Brasile 146
VN - Vietnam 136
IE - Irlanda 134
NL - Olanda 133
TW - Taiwan 125
AU - Australia 124
ID - Indonesia 124
BE - Belgio 112
PK - Pakistan 111
TR - Turchia 102
CA - Canada 101
JP - Giappone 90
MY - Malesia 87
BD - Bangladesh 50
AT - Austria 46
EG - Egitto 46
ZA - Sudafrica 45
NG - Nigeria 41
ET - Etiopia 40
IQ - Iraq 40
SA - Arabia Saudita 36
CH - Svizzera 34
NO - Norvegia 33
PH - Filippine 31
NZ - Nuova Zelanda 27
GH - Ghana 25
RO - Romania 24
AE - Emirati Arabi Uniti 23
ES - Italia 23
PL - Polonia 23
TH - Thailandia 22
EC - Ecuador 19
IL - Israele 19
MX - Messico 17
PT - Portogallo 17
CZ - Repubblica Ceca 14
MA - Marocco 13
CO - Colombia 10
DK - Danimarca 10
BW - Botswana 9
EU - Europa 9
GR - Grecia 9
NP - Nepal 9
BN - Brunei Darussalam 8
DZ - Algeria 8
LT - Lituania 8
KE - Kenya 6
LK - Sri Lanka 6
LY - Libia 6
PE - Perù 6
TN - Tunisia 6
CL - Cile 5
CR - Costa Rica 5
HU - Ungheria 5
JM - Giamaica 5
JO - Giordania 5
MM - Myanmar 5
RS - Serbia 5
AL - Albania 4
BF - Burkina Faso 4
BG - Bulgaria 4
BO - Bolivia 4
LS - Lesotho 4
NI - Nicaragua 4
UG - Uganda 4
ZM - Zambia 4
BH - Bahrain 3
BT - Bhutan 3
GA - Gabon 3
HR - Croazia 3
LB - Libano 3
LU - Lussemburgo 3
SN - Senegal 3
AZ - Azerbaigian 2
BJ - Benin 2
CM - Camerun 2
EE - Estonia 2
GT - Guatemala 2
KH - Cambogia 2
KZ - Kazakistan 2
NA - Namibia 2
RW - Ruanda 2
SK - Slovacchia (Repubblica Slovacca) 2
SO - Somalia 2
SV - El Salvador 2
Totale 34.720
Salva come PNG Salva come JPEG
Città #
Fairfield 3.662
Woodbridge 2.452
Houston 1.996
Chandler 1.933
Ashburn 1.839
Seattle 1.518
Jacksonville 1.356
Cambridge 1.280
Wilmington 1.176
Ann Arbor 916
Nyköping 730
Singapore 686
Lawrence 445
Roxbury 435
Nanjing 350
Beijing 344
Des Moines 303
New York 228
Boardman 184
Hong Kong 160
San Diego 146
Bari 139
Princeton 135
Dublin 122
Santa Clara 105
Dearborn 100
Nanchang 96
Brooklyn 95
Los Angeles 92
Brussels 91
London 91
Paris 88
Shenyang 88
Dong Ket 86
Hebei 83
Jakarta 81
Inglewood 78
Jiaxing 77
Helsinki 70
Kuala Lumpur 63
Central 60
Munich 59
Tianjin 56
Changsha 51
Taranto 49
Tehran 48
Norwalk 45
Redwood City 45
Taipei 43
Guangzhou 40
Melbourne 39
Pune 39
Neunburg vorm Wald 38
Ruvo Di Puglia 38
Washington 38
Strasbourg 37
Nuremberg 35
Tokyo 34
Hefei 30
Istanbul 30
Toronto 30
Milan 28
Shanghai 28
Frankfurt am Main 26
San Mateo 26
Dhaka 25
Liverpool 25
Manchester 25
Vienna 25
Accra 24
Berlin 24
Mumbai 24
Ostuni 24
Augusta 23
Hanoi 23
Jinan 23
Kunming 23
Lahore 23
Leeds 23
San Jose 23
Ardabil 22
Hyderabad 22
Sydney 22
Falls Church 21
New Taipei 21
Sulaymaniyah 21
Auburn Hills 20
Chicago 20
Rome 20
San Francisco 20
Brisbane 19
Delhi 18
Leawood 18
Nowon-gu 18
Cairo 17
Coventry 16
Jeddah 16
Leverkusen 16
Ningbo 16
Southwark 16
Totale 25.647
Salva come PNG Salva come JPEG
Nome #
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013 3.683
Prevalence of cognitive impairment and dementia in a population based study in Southern Italy: The Great Age study 269
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review 248
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging 179
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 174
Age-related hearing impairment—a risk factor and frailty marker for dementia and AD 164
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 149
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 147
Comparative evaluation of two immunoassays for cerebrospinal fluid β-Amyloid 1–42 measurement 144
Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging 142
Social dysfunction in older age and relationships with cognition, depression, and apathy: The GreatAGE Study 138
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 137
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype 136
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 134
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 134
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 133
Qualitative analysis of the capacity to consent to treatment in patients with a chronic neurodegenerative disease. Alzheimer's Disease. 130
Plasma β-amyloid 1–42 reference values in cognitively normal subjects 129
Age-related hearingimpairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms 127
Prefrontal activity and connectivity with basal ganglia during performance of complex cognitive tasks is associated with apathy in healthy subjects 127
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study 125
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial 125
Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort 125
COGNITIVE-HD study: Protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis 123
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 123
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 122
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 121
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 117
Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres 117
The prevalence of peripheral and central hearing impairment and its relation to cognition in older adults 116
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 114
Unreported financial disclosures in a study of migraine and cardiovascular disease 113
Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia 113
Evaluation of endothelial function and cardiovascular risk in non-obese patients with slight degree of obstructive sleep apnea syndrome 112
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial 112
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease 112
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 111
Bioelectrical correlates of emotional changes induced by environmental sound and colour: from virtual reality to real life 111
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 110
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 110
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 109
Epidemiology of age related hearing loss: A review 109
The Role of Hearing Impairment in Cognitive Decline: Need for the Special Sense Assessment in Evaluating Cognition in Older Age 109
Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis 109
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 108
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease 107
Tau aggregation inhibitors: The future of Alzheimer's pharmacotherapy? 107
Factors predicting survival in ALS: a multicenter Italian study 107
The age-related central auditory processing disorder: Silent impairment of the cognitive ear 107
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia 107
Epidemiology of neurodegenerative diseases 107
Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy 106
The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset 106
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 105
Apolipoprotein E genotype does not influence the progression of multiple sclerosis 104
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. 103
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis 103
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 102
Screening for aphasia in neurodegeneration for the diagnosis of patients with primary progressive aphasia: Clinical validity and psychometric properties 102
null 101
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke 101
Cognitive frailty: a potential target for secondary prevention of dementia 101
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 101
null 100
Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. 100
Classification of healthy subjects and Alzheimer's disease patients with dementia from cortical sources of resting state EEG rhythms: A study using artificial neural networks 98
Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer's disease patients 98
A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy 97
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. 97
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 97
Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis 95
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial 95
null 95
Agreement among neurologists on the clinical diagnosis of dystonia at different body sites 95
Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases 95
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 94
Metabolic syndrome, mild cognitive impairment, and dementia 93
Acute changes in blood-CSF barrier permselectivity to serum proteins after intrathecal methotrexate and CNS irradiation 93
Bipolar disorder and frontotemporal dementia: An intriguing association 93
Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline 93
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 93
Accuracy of clinical diagnosis of Parkinson disease. A systematic review and meta-analysis 93
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies 92
Seborrheic dermatitis, increased sebum excretion, and Parkinson's disease: a survey of (im)possible links 91
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease. 91
Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis 91
Age-specific ALS incidence: a dose–response meta-analysis 91
Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature 91
The ever-stimulating association of smoking and coffee and Parkinson's disease 90
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy 90
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging 90
Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017 89
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 88
Response to Letter to the Editor: “Plasma β-amyloid1–42 reference values” 88
Early pathological gambling in co-occurrence with semantic variant primary progressive aphasia: A case report 87
Multicentre, population-based, case-control study of particulates, combustion products and amyotrophic lateral sclerosis risk 87
Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study 87
Long-term mortality after a first episode of status epilepticus 86
Environmental risk factors for Parkinson's disease in an urban multiethnic community 86
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases 86
Totale 14.792
Salva come PNG Salva come JPEG
Categoria #
all - tutte 141.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 141.136
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.393 0 0 0 0 0 0 0 870 1.103 483 706 231
2020/20215.719 389 336 402 552 632 390 826 435 455 631 354 317
2021/20222.928 148 177 21 133 158 340 77 156 243 211 434 830
2022/20234.752 722 468 304 427 563 548 96 574 803 38 133 76
2023/20244.500 347 629 357 335 425 1.095 484 440 88 44 51 205
2024/20253.704 250 224 905 474 255 822 704 70 0 0 0 0
Totale 36.168